跳至主要内容
临床试验/CTRI/2025/09/095493
CTRI/2025/09/095493尚未招募不适用

Clinical evaluation of Nidrakar Churna and Shiropichu with Ksheerbala Taila in Anidra (Insomnia)

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年10月8日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
1. Improvement in Insomnia Severity Index (ISI) score

研究概览

简要总结

This is an open-label, single-arm clinical study to evaluate the efficacy of Nidrakar Churna (oral) and Shiropichu with Ksheerbala Taila in the management of Anidra (Insomnia). A total of 60 patients fulfilling DSM-5 criteria for insomnia will be enrolled from the OPD of Kayachikitsa, Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar. The intervention will be administered for 60 days, with assessments at day 1, day 30, and day 60. Primary outcomes will be measured using classical Ayurvedic parameters and the Insomnia Severity Index (ISI) scale. The study aims to provide an effective and safe Ayurvedic therapeutic approach for insomnia.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients having classical symptoms of Anidra such as Tandra, Angamarda, Jrumbha, Arati, Klama, Shirashoola and Akshigaurava
  • Patients fulfilling DSM V Criteria for Insomnia
  • Both new and previously treated cases will be included
  • Patients aged between 18 and 70 years
  • Patients of either gender irrespective of their race, occupation, religion and socio economic status
  • Patients who will be capable and willing to adhere to all study related instructions, attend all scheduled visits and sign the consent form.

排除标准

  • Physiological conditions like pregnancy, lactation and puerperal stage
  • History of any acute systemic pathological illness such as fever in the preceding one month
  • Patients with insomnia comorbid with other medical conditions
  • Patients with impaired Renal, Hepatic or Cardiac function
  • Patients having drug or alcohol dependency
  • Exaggeration of previous psychiatric illness such as major depression and mania
  • Use of hypnotics or other therapies for insomnia within the past 4 weeks.

结局指标

主要结局

1. Improvement in Insomnia Severity Index (ISI) score

时间窗: Day 1, Day 30, Day 60

2. Improvement in Ayurvedic symptom grading (Tandra, Akshigaurava, Shirashoola, Angamarda, Arati, Klama, Jrumbha)

时间窗: Day 1, Day 30, Day 60

次要结局

  • Safety and tolerability of the intervention(Day 1, Day 30, Day 60)

研究者

发起方
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

KANIKA

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan

研究点 (1)

Loading locations...

相似试验